Celsion Corporation (NASDAQ:CLSN)

CAPS Rating: 1 out of 5

A biotechnology company dedicated to furthering the development and commercialization of treatment systems for cancer and other diseases using focused heat energy in combination with other therapeutic devices or heat-activated genes.

Recs

0
Player Avatar pchop123 (78.33) Submitted: 11/20/2012 6:32:28 PM : Underperform Start Price: $27.45 CLSN Score: -20.72

Up in price beyond reality

Featured Broker Partners


Advertisement